Literature DB >> 21861491

The evolution of the protein corona around nanoparticles: a test study.

Martin Lundqvist1, Johannes Stigler, Tommy Cedervall, Tord Berggård, Michelle B Flanagan, Iseult Lynch, Giuliano Elia, Kenneth Dawson.   

Abstract

The importance of the protein corona formed around nanoparticles upon entering a biological fluid has recently been highlighted. This corona is, when sufficiently long-lived, thought to govern the particles' biological fate. However, even this long-lived "hard" corona evolves and re-equilibrates as particles pass from one biological fluid to another, and may be an important feature for long-term fate. Here we show the evolution of the protein corona as a result of transfer of nanoparticles from one biological fluid (plasma) into another (cytosolic fluid), a simple illustrative model for the uptake of nanoparticles into cells. While no direct comparison can be made to what would happen in, for example, the uptake pathway, the results confirm that significant evolution of the corona occurs in the second biological solution, but that the final corona contains a "fingerprint" of its history. This could be evolved to map the transport pathways utilized by nanoparticles, and eventually to predict nanoparticle fate and behavior.
© 2011 American Chemical Society

Mesh:

Substances:

Year:  2011        PMID: 21861491     DOI: 10.1021/nn202458g

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  148 in total

1.  Spherical nucleic acid nanoparticle conjugates enhance G-quadruplex formation and increase serum protein interactions.

Authors:  Alyssa B Chinen; Chenxia M Guan; Chad A Mirkin
Journal:  Angew Chem Int Ed Engl       Date:  2014-11-13       Impact factor: 15.336

Review 2.  Nanoparticle Probes for the Detection of Cancer Biomarkers, Cells, and Tissues by Fluorescence.

Authors:  Alyssa B Chinen; Chenxia M Guan; Jennifer R Ferrer; Stacey N Barnaby; Timothy J Merkel; Chad A Mirkin
Journal:  Chem Rev       Date:  2015-08-27       Impact factor: 60.622

3.  Experimental challenges regarding the in vitro investigation of the nanoparticle-biocorona in disease states.

Authors:  Sherleen Xue-Fu Adamson; Zhoumeng Lin; Ran Chen; Lisa Kobos; Jonathan Shannahan
Journal:  Toxicol In Vitro       Date:  2018-05-05       Impact factor: 3.500

4.  Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology.

Authors:  Stefan Tenzer; Dominic Docter; Jörg Kuharev; Anna Musyanovych; Verena Fetz; Rouven Hecht; Florian Schlenk; Dagmar Fischer; Klytaimnistra Kiouptsi; Christoph Reinhardt; Katharina Landfester; Hansjörg Schild; Michael Maskos; Shirley K Knauer; Roland H Stauber
Journal:  Nat Nanotechnol       Date:  2013-09-22       Impact factor: 39.213

5.  Nanoparticles: Tracking protein corona over time.

Authors:  Martin Lundqvist
Journal:  Nat Nanotechnol       Date:  2013-09-22       Impact factor: 39.213

Review 6.  Exploiting endocytosis for nanomedicines.

Authors:  Akin Akinc; Giuseppe Battaglia
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-11-01       Impact factor: 10.005

7.  An Integrative Proteomic/Lipidomic Analysis of the Gold Nanoparticle Biocorona in Healthy and Obese Conditions.

Authors:  Lisa M Kobos; Saeed Alqatani; Christina R Ferreira; Uma K Aryal; Victoria Hedrick; Tiago J P Sobreira; Jonathan H Shannahan
Journal:  Appl In Vitro Toxicol       Date:  2019-09-17

8.  Comparison of nanotube-protein corona composition in cell culture media.

Authors:  Jonathan H Shannahan; Jared M Brown; Ran Chen; Pu Chun Ke; Xianyin Lai; Somenath Mitra; Frank A Witzmann
Journal:  Small       Date:  2013-01-16       Impact factor: 13.281

9.  Protein Interactions with Nanoparticle Surfaces: Highlighting Solution NMR Techniques.

Authors:  Y Randika Perera; Rebecca A Hill; Nicholas C Fitzkee
Journal:  Isr J Chem       Date:  2019-09-19       Impact factor: 3.333

10.  Protein corona significantly reduces active targeting yield.

Authors:  Vahid Mirshafiee; Morteza Mahmoudi; Kaiyan Lou; Jianjun Cheng; Mary L Kraft
Journal:  Chem Commun (Camb)       Date:  2013-03-28       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.